Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

7.7%

6 terminated out of 78 trials

Success Rate

88.5%

+2.0% vs benchmark

Late-Stage Pipeline

12%

9 trials in Phase 3/4

Results Transparency

20%

9 of 46 completed with results

Key Signals

9 with results88% success

Data Visualizations

Phase Distribution

66Total
Not Applicable (26)
Early P 1 (2)
P 1 (15)
P 2 (14)
P 3 (2)
P 4 (7)

Trial Status

Completed46
Unknown16
Recruiting6
Terminated6
Not Yet Recruiting2
Withdrawn1

Trial Success Rate

88.5%

Benchmark: 86.5%

Based on 46 completed trials

Clinical Trials (78)

Showing 20 of 20 trials
NCT05461157Not ApplicableEnrolling By Invitation

Preoperative Silicone Ointment and Wound Healing

NCT01619553RecruitingPrimary

Genetic Analysis of Keloids

NCT07526168Not ApplicableNot Yet RecruitingPrimary

Intralesional Cryosurgery Alone Versus Combined With 5-FU and Triamcinolone for Keloids

NCT07420166Not ApplicableCompletedPrimary

Comparison of Intralesional Triamcinolone Acetonide Treatment With Intralesional Verapamil Hydrochloride in Keloids

NCT04722263Not ApplicableRecruitingPrimary

Radiotherapy for Keloids

NCT07263100Not ApplicableCompleted

Comparative Study Between Intralesional Corticosteroid Injection Alone and Combined Intralesional Corticosteroid Injection With Either Long-pluse Nd YAG or Erbium Yag for Treating Hypertrophic or Keloid Scars

NCT05330078Early Phase 1CompletedPrimary

Examining the Therapeutic Potential of Botulinum Toxin Type A in the Treatment of Keloids

NCT06373458Phase 2RecruitingPrimary

Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy

NCT05128383Phase 2CompletedPrimary

Study to Assess Efficacy and Safety of Dupilumab in the Treatment of Keloids

NCT04988022Phase 4CompletedPrimary

Dupilumab in the Treatment of Keloids

NCT04827875Phase 1CompletedPrimary

Safety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following Keloidectomy

NCT03312166Not ApplicableCompletedPrimary

Compressive Device to Prevent Keloïd Scars Recurrence [SCARWARS]

NCT04824612Not ApplicableCompletedPrimary

Photobiomodulation and the Intralesional Administration of Corticoid in the Keloid Surgery.

NCT06138964Phase 2RecruitingPrimary

Comparing the Effect of siSPARC Microneedle Patch Versus siSPARC+siLR4A Microneedle Patch on Post-surgical Scars

NCT06431360Not ApplicableRecruitingPrimary

Effect of Strontium-90 Brachytherapy Combined With Hyperthermia in the Treatment of Keloid

NCT01125137Not ApplicableCompletedPrimary

Case-control Study on Matrix Metalloproteinase Levels in Tissue in Patients With Keloid Scar

NCT04844840Phase 2CompletedPrimary

A Study for Safety and Efficacy Evaluation of Various Doses of STP705 in Reducing Keloid Recurrence

NCT06230146Phase 1Not Yet RecruitingPrimary

Efficacy and Safety of Fractional CO2 Laser Combined With Intralesional Insulin, Botulinum Toxin or Triamcinolone Acetonide in the Treatment of Keloid: A Clinical, Dermoscopic and Immunohistochemical Study.

NCT05893108Phase 1UnknownPrimary

Ethosomal Gel Bearing Losartan 5% for Keloid Treatment

NCT06034587CompletedPrimary

Multimodal Ultrasound Imaging Assessment on Keloid

Scroll to load more

Research Network

Activity Timeline